The effects of vitamin C on DDP-induced anemia in rats

References

• Anat H, Inanc SE, Dalay N, et al. (1993). Effect of cisplatin on erythropoietin and iron changes. Eur J Cancer 29:777
   Web of Science ®Google Scholar
• Anderson D. (1996). Antioxidant defenses against reactive oxygen species causing genetic and other damage. Mutat Res 350:103–8
   PubMed Web of Science ®Google Scholar
• Atessahin A, Yilmaz S, Karahan I, et al. (2005). Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology 212:116–23
   PubMed Web of Science ®Google Scholar
• Baldwin MD, Zhou XJ, Ing TS, Vaziri ND. (1998). Erythropoietin ameliorates anemia of cisplatin induced acute renal failure. J ASAIO 44:44–7
   PubMed Web of Science ®Google Scholar
• Baliga R, Zhang Z, Baliga M, et al. (1998). In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53:394–401
   PubMed Web of Science ®Google Scholar
• Bokkel Huinink WW, Swart CA, Van Toorn DW, et al. (1998). Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy. Med Oncol 15:174–82
   PubMed Web of Science ®Google Scholar
• Cazzola M. (2000). Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin. Med Oncol 17:S11–16
   Web of Science ®Google Scholar
• Chirino YI, Pedraza-Chaverr J. (2009). Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exper Toxicol Pathol 61:223–42
   PubMed Web of Science ®Google Scholar
• Colpi GM, Contalbi GF, Nerva F, et al. (2004). Testicular function following chemo-radiotherapy. Eur J Obstet Gynecol Reprod Biol 113:S2–6
   PubMed Web of Science ®Google Scholar
• Fjornes T, Wiedemann GJ, Sack K, et al. (1998). Serum erythropoietin and creatinine concentrations as predictipe factors for response to recombinant human erythropoietin treatment in anaemic tumor patients on chemotherapy. Oncol Reports 5:81–6
   PubMed Web of Science ®Google Scholar
• Gao LP, Ma RY, Cheng SZ. (2006). Changes of serum erythropoietin during cisplatin- or 5-fluorouracil-induced anemia in rats. Toxicol Mech Methods 16:501–6
   PubMed Web of Science ®Google Scholar
• Greggi Antunes LM, Darin JD, Bianchi MdeP. (2000). Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res 41:405–11
   PubMed Web of Science ®Google Scholar
• Heddens D, Alberts DS, Hannigan EV, et al. (2002). Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment. Gynecol Oncol 86:239–43
   PubMed Web of Science ®Google Scholar
• Howell SJ, Shalet SM. (2005). Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 34:12–17
   PubMedGoogle Scholar
• Martinis BS, Bianchi M deP. (2001). Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats. Pharmacol Res 44:317–20
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Endoh K, Kamisango K, et al. (1990). Effect of recombinant human erythropoietin on cancer drug-induced anaemia. Br J Haem 75:463–8
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Osmond MK, Pugh CW, et al. (1993). Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44:149–62
   Web of Science ®Google Scholar
• Mujais SK, Beru N, Pullman TN, Goldwasser E. (1999). Erythropoietin is produced by tubular cells of the rat kidney. Cell Biochem Biophys 30:153–66
   PubMedGoogle Scholar
• Muthuvel R, Venkataraman P, Krishnamoorthy G, et al. (2006). Antioxidant effect of ascorbic acid on PCB (Aroclor 1254) induced oxidative stress in hypothalamus of albino rats. Clin Chim Acta 365:297–303
   PubMed Web of Science ®Google Scholar
• Naziroglu M, Karaoglu A, Aksoy AO. (2004). Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 195:221–30
   PubMed Web of Science ®Google Scholar
• Pérez-Rojas JM, Guerrero-Beltrán CE, Cruz C, et al. (2011). Preventive effect of tert-butylhydroquinone on cisplatin-induced nephrotoxicity in rats. Food Chem Toxicol 49:2631–7
   PubMed Web of Science ®Google Scholar
• Schuster SJ, Koury ST, Bohrer M, et al. (1992). Cellular sites of extrarenal and renal erythropoietin production in anaemic rats. Br J Haem 81:153–9
   PubMed Web of Science ®Google Scholar
• Sueishi K, Mishima K, Makino K, et al. (2002). Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur J Pharmacol 451:203–8
   PubMed Web of Science ®Google Scholar
• Wood PA, Hrushesky WJ. (1995). Cisplatin-associated anemia: an erythropoietin deficiency syndrome. J Clin Invest 95:1650–9
   PubMed Web of Science ®Google Scholar
• Yildirim Z, Sogut S, Odaci E, et al. (2003). Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol Res 47:149–56
   PubMed Web of Science ®Google Scholar
• Zhang HL, Gao LP, Leng HT, Li Z. (2012). Protective effect of Lycium barbarum polysaccharide against cisplatin-induced nephrotoxicity in Rats. Food Sci 33: 268–71 (in Chinese)
   Google Scholar